Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Five-year outcomes of an oropharynx-directed treatment approach for unknown primary of the head and neck.

Hu KS, Mourad WF, Gamez ME, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney BE, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB.

Oral Oncol. 2017 Jul;70:14-22. doi: 10.1016/j.oraloncology.2017.05.001. Epub 2017 May 13.

PMID:
28622886
2.

Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization.

Hu KS, Mourad WF, Gamez M, Safdieh J, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney B, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB.

Head Neck. 2017 Aug;39(8):1647-1654. doi: 10.1002/hed.24806. Epub 2017 May 5.

PMID:
28474380
3.

Molecular target based combinational therapeutic approaches in thyroid cancer.

Rajoria S, Suriano R, George AL, Kamat A, Schantz SP, Geliebter J, Tiwari RK.

J Transl Med. 2012 May 1;10:81. doi: 10.1186/1479-5876-10-81.

4.

Non-cancer-related deaths from suicide, cardiovascular disease, and pneumonia in patients with oral cavity and oropharyngeal squamous carcinoma.

Yu GP, Mehta V, Branovan D, Huang Q, Schantz SP.

Arch Otolaryngol Head Neck Surg. 2012 Jan;138(1):25-32. doi: 10.1001/archoto.2011.236.

PMID:
22249625
5.

Reduced Cx43 gap junction plaque expression differentiates thyroid carcinomas from benign disease.

Darr EA, Patel AD, Yu G, Komorowski Z, McCormick S, Tiwari R, Schantz SP, Geliebter J.

Arch Otolaryngol Head Neck Surg. 2011 Nov;137(11):1161-5. doi: 10.1001/archoto.2011.186.

PMID:
22106244
6.

Improved survival among patients with base of tongue and tonsil cancer in the United States.

Yu GP, Mehta V, Branovan D, Huang Q, Hashibe M, Zhang ZF, Schantz SP.

Cancer Causes Control. 2012 Jan;23(1):153-64. doi: 10.1007/s10552-011-9864-y. Epub 2011 Nov 20.

PMID:
22101504
7.

Estradiol-mediated tumor neo-vascularization.

Rajoria S, Suriano R, Wilson YL, George AL, Geliebter J, Schantz SP, Tiwari RK.

Oncol Lett. 2011 May;2(3):453-457. Epub 2011 Mar 21.

8.

Native fluorescence spectroscopic evaluation of chemotherapeutic effects on malignant cells using nonnegative matrix factorization analysis.

Pu Y, Tang GC, Wang WB, Savage HE, Schantz SP, Alfano RR.

Technol Cancer Res Treat. 2011 Apr;10(2):113-20.

PMID:
21381789
9.

Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.

Rajoria S, Suriano R, George A, Shanmugam A, Schantz SP, Geliebter J, Tiwari RK.

PLoS One. 2011 Jan 18;6(1):e15879. doi: 10.1371/journal.pone.0015879.

10.

3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study.

Rajoria S, Suriano R, Parmar PS, Wilson YL, Megwalu U, Moscatello A, Bradlow HL, Sepkovic DW, Geliebter J, Schantz SP, Tiwari RK.

Thyroid. 2011 Mar;21(3):299-304. doi: 10.1089/thy.2010.0245. Epub 2011 Jan 22.

11.

3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways.

Rajoria S, Suriano R, Wilson YL, Schantz SP, Moscatello A, Geliebter J, Tiwari RK.

Oncol Rep. 2011 Feb;25(2):491-7. doi: 10.3892/or.2010.1076. Epub 2010 Dec 7.

PMID:
21152869
12.
13.

Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups.

Yu GP, Li JC, Branovan D, McCormick S, Schantz SP.

Thyroid. 2010 May;20(5):465-73. doi: 10.1089/thy.2008.0281.

PMID:
20384488
14.

Metastatic phenotype is regulated by estrogen in thyroid cells.

Rajoria S, Suriano R, Shanmugam A, Wilson YL, Schantz SP, Geliebter J, Tiwari RK.

Thyroid. 2010 Jan;20(1):33-41. doi: 10.1089/thy.2009.0296.

15.

Extent of surgery affects papillary thyroid cancer.

Yu GP, Schantz SP.

Ann Surg. 2009 Mar;249(3):549-50; author reply 550. doi: 10.1097/SLA.0b013e31819ac700. No abstract available.

PMID:
19247059
16.

Five-year survival rates and time trends of laryngeal cancer in the US population.

Cosetti M, Yu GP, Schantz SP.

Arch Otolaryngol Head Neck Surg. 2008 Apr;134(4):370-9. doi: 10.1001/archotol.134.4.370.

PMID:
18427002
17.

A hormonal association between estrogen metabolism and proliferative thyroid disease.

Chan EK, Sepkovic DW, Yoo Bowne HJ, Yu GP, Schantz SP.

Otolaryngol Head Neck Surg. 2006 Jun;134(6):893-900.

PMID:
16730526
18.

Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases.

Suriano R, Lin Y, Ashok BT, Schaefer SD, Schantz SP, Geliebter J, Tiwari RK.

J Proteome Res. 2006 Apr;5(4):856-61.

PMID:
16602693
19.

Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States).

Yu GP, Schantz SP, Neugut AI, Zhang ZF.

Cancer Causes Control. 2006 May;17(4):411-20.

PMID:
16596293
20.

A simple method for fixation and microdissection of frozen fresh tissue sections for molecular cytogenetic analysis of cancers.

Huang Q, Sacks PG, Mo J, McCormick SA, Iacob CE, Guo L, Schaefer S, Schantz SP.

Biotech Histochem. 2005 May-Aug;80(3-4):147-56.

PMID:
16298900
21.

3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease.

Tadi K, Chang Y, Ashok BT, Chen Y, Moscatello A, Schaefer SD, Schantz SP, Policastro AJ, Geliebter J, Tiwari RK.

Biochem Biophys Res Commun. 2005 Nov 25;337(3):1019-25. Epub 2005 Oct 3.

PMID:
16219298
22.

Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.

Frank DK, Hu KS, Culliney BE, Persky MS, Nussbaum M, Schantz SP, Malamud SC, Holliday RA, Khorsandi AS, Sessions RB, Harrison LB.

Laryngoscope. 2005 Jun;115(6):1015-20.

PMID:
15933512
23.

The fluorescence of thyroid tissue.

Pitman MJ, Rosenthal JM, Savage HE, Yu G, McCormick SA, Katz A, Alfano RR, Schantz SP.

Otolaryngol Head Neck Surg. 2004 Nov;131(5):623-7.

PMID:
15523437
24.

Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk.

Elahi A, Bendaly J, Zheng Z, Muscat JE, Richie JP Jr, Schantz SP, Lazarus P.

Cancer. 2003 Aug 15;98(4):872-80.

25.

Epoxide hydrolase genotype and orolaryngeal cancer risk: interaction with GSTM1 genotype.

Park JY, Schantz SP, Lazarus P.

Oral Oncol. 2003 Jul;39(5):483-90.

26.

Noninvasive native fluorescence imaging of head and neck tumors.

Katz A, Savage HE, Schantz SP, McCormick SA, Alfano RR.

Technol Cancer Res Treat. 2002 Feb;1(1):9-15.

PMID:
12614172
27.

Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression.

Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schäffer AA, Desper R, Schantz SP.

Genes Chromosomes Cancer. 2002 Jun;34(2):224-33.

PMID:
11979556
28.

Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer.

Schantz SP, Yu GP.

Arch Otolaryngol Head Neck Surg. 2002 Mar;128(3):268-74.

PMID:
11886342
29.

Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk.

Zheng Z, Park JY, Guillemette C, Schantz SP, Lazarus P.

J Natl Cancer Inst. 2001 Sep 19;93(18):1411-8.

PMID:
11562393
30.

Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.

Liu S, Park JY, Schantz SP, Stern JC, Lazarus P.

Oral Oncol. 2001 Jul;37(5):437-45.

31.

Estrogen metabolism as a risk factor for head and neck cancer.

Yoo HJ, Sepkovic DW, Bradlow HL, Yu GP, Sirilian HV, Schantz SP.

Otolaryngol Head Neck Surg. 2001 Mar;124(3):241-7.

PMID:
11240983
32.

A survey of smoking status and cancer risk perceptions among participants attending a hospital-based head and neck screening program.

Ostroff JS, Hay JL, Schantz SP, Maher MM.

Psychol Health. 2000 Nov;14(6):979-90. doi: 10.1080/08870440008407362.

PMID:
22175257
33.

Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma.

Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP, Yu GP, Hsu TC, Schantz SP.

Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1043-9.

34.

Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors.

Huang Q, Schantz SP, Rao PH, Mo J, McCormick SA, Chaganti RS.

Genes Chromosomes Cancer. 2000 Aug;28(4):395-403.

PMID:
10862048
35.

Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers.

Schantz SP, Huang Q, Shah K, Murty VV, Hsu TC, Yu G, Andersen PE, Huvos AG, Chaganti RS.

Carcinogenesis. 2000 Jun;21(6):1239-46.

PMID:
10837016
36.

Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk.

Park JY, Schantz SP, Stern JC, Kaur T, Lazarus P.

Pharmacogenetics. 1999 Aug;9(4):497-504. Erratum in: Pharmacogenetics 2000 Jun;10(4):371.

PMID:
10780269
37.

Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians.

Park LY, Muscat JE, Kaur T, Schantz SP, Stern JC, Richie JP Jr, Lazarus P.

Pharmacogenetics. 2000 Mar;10(2):123-31.

PMID:
10762000
38.

Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer.

Yu GP, Zhang ZF, Hsu TC, Spitz MR, Schantz SP.

Cancer Lett. 1999 Nov 1;146(1):93-101.

PMID:
10656614
39.

Marijuana use and increased risk of squamous cell carcinoma of the head and neck.

Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP, Yu GP, Marshall JR, Hsu TC, Schantz SP.

Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1071-8.

40.

Subsurface tumor progression investigated by noninvasive optical second harmonic tomography.

Guo Y, Savage HE, Liu F, Schantz SP, Ho PP, Alfano RR.

Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10854-6.

41.

Native fluorescence spectroscopy of normal and malignant epithelial cells.

Ganesan S, Sacks PG, Yang Y, Katz A, Al-Rawi M, Savage HE, Schantz SP, Alfano RR.

Cancer Biochem Biophys. 1998 Nov;16(4):365-73.

PMID:
9925283
42.

Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector.

Carew JF, Federoff H, Halterman M, Kraus DH, Savage H, Sacks PG, Schantz SP, Shah JP, Fong Y.

Am J Surg. 1998 Nov;176(5):404-8.

PMID:
9874422
43.

Green tea regulates cell cycle progression in oral leukoplakia.

Khafif A, Schantz SP, al-Rawi M, Edelstein D, Sacks PG.

Head Neck. 1998 Sep;20(6):528-34.

PMID:
9702540
44.

A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck.

Harrison LB, Raben A, Pfister DG, Zelefsky M, Strong E, Shah JP, Spiro RH, Shaha A, Kraus DH, Schantz SP, Carper E, Bodansky B, White C, Bosl G.

Head Neck. 1998 Sep;20(6):497-503.

PMID:
9702535
45.

Squamous cell carcinoma of the tongue in young patients: a matched-pair analysis.

Friedlander PL, Schantz SP, Shaha AR, Yu G, Shah JP.

Head Neck. 1998 Aug;20(5):363-8.

PMID:
9663661
46.

Phorbol ester-mediated induction of cyclooxygenase-2 gene expression is inhibited by retinoids.

Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Dannenberg AJ.

Ann N Y Acad Sci. 1997 Dec 29;833:173-8. No abstract available.

PMID:
9616751
47.

In vivo native cellular fluorescence and histological characteristics of head and neck cancer.

Schantz SP, Kolli V, Savage HE, Yu G, Shah JP, Harris DE, Katz A, Alfano RR, Huvos AG.

Clin Cancer Res. 1998 May;4(5):1177-82.

48.

Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers.

Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz SP.

Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):351-4.

49.

Molecular support for field cancerization in the head and neck.

Lydiatt WM, Anderson PE, Bazzana T, Casale M, Hughes CJ, Huvos AG, Lydiatt DD, Schantz SP.

Cancer. 1998 Apr 1;82(7):1376-80.

PMID:
9529031
50.

p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use.

Lazarus P, Sheikh SN, Ren Q, Schantz SP, Stern JC, Richie JP Jr, Park JY.

Carcinogenesis. 1998 Mar;19(3):509-14.

PMID:
9525287

Supplemental Content

Loading ...
Support Center